Cannata_foreword_longer.qxp 25/7/07 2:16 pm Page 6
Foreword
Jorge B Cannata-Andía
President, European Renal Association – European Dialysis and Transplant Association (ERA-EDTA)
Jorge B Cannata-Andía is President of the European Renal Association – European Dialysis and Transplant Association (ERA-EDTA). He is also
Head of the Bone and Mineral Research Unit at the Reina Sofia Research Institute of the Hospital Universitario Central de Asturias, and
Professor of Medicine at the University of Oviedo, Spain. Professor Cannata-Andía’s research activities in bone metabolic disorders and
vascular calcifications have attracted more than 20 Ministry of Health and Science sponsorships and more than 30 research awards. His
research findings have contributed to medical literature with more than 300 original articles and editorials in peer-reviewed journals.
W
elcome to this first issue of European Renal Disease 2007, which covers a wide range of interesting issues in the
field of chronic kidney disease (CKD). Kidney disease is a leading cause of mortality, both in Europe and worldwide,
and the number of patients requiring the care of nephrologists is ever rising. This review aims to provide an overview of
current trends and future developments in the prevention, diagnosis and treatment of kidney disease.
The first section is devoted to several current issues in clinical nephrology, including an article on the problem and assessment
of acute kidney injury. Moving on to more specific issues in the management of complications of renal disease, there is a
thought-provoking section on anaemia. This discusses the different profiles, benefits and limitations of erythropoiesis-
stimulating agents in its management.
In addition, the hot topics of calcium phosphate metabolism, vascular calcifications, hypertension and cardiovascular risk are
addressed by several investigators, underlining the role of high serum phosphate in morbidity and mortality in patients with
CKD and the need for better phosphate control. Several authors discuss these issues. Moreover, there is a specific overview
of the additional risk of mineral and bone disorder in CKD patients.
A series of articles covering the various aspects of haemodialysis and peritoneal dialysis are included, followed by the latest
news in different therapies for better immunosuppression and tolerance in transplant recipients – including a very interesting
look at organ quality.
To conclude, there is a section on the importance of nutrition in managing the care of CKD patients. This includes discussion
of the role of growth hormones on biomarkers and the importance of nutritional support for haemodialysis patients.
This broad review contains many interesting articles written by respected nephrologists, providing the community,
nephrology consultants and healthcare directors with useful information about new developments in the diagnosis and
management of CKD.
I would like to thank all the contributing authors for their excellent reviews, which I believe you will find extremely useful in
your general practice, and of course our advisory panel and media partners for their continued support of European Renal
Disease 2007. ■
6 EUROPEAN RENAL DISEASE 2007
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74